Duncan Gregory Scott 13D and 13G filings for Virios Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 4:09 pm Purchase |
2023-02-13 | 13G | Virios Therapeutics, Inc. VIRI |
Duncan Gregory Scott | 501,715 2.700% |
40,833 (+8.86%) |
Filing |
| 2022-02-14 09:46 am Purchase |
2021-12-31 | 13G | Virios Therapeutics, Inc. VIRI |
Duncan Gregory Scott | 460,882 5.300% |
21,057 (+4.79%) |
Filing |
| 2021-02-16 4:44 pm Purchase |
2020-12-31 | 13G | Virios Therapeutics, Inc. VIRI |
Duncan Gregory Scott | 439,825 5.030% |
439,825 (New Position) |
Filing |